PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO
THALASSA 2.0
Phase 2 small_molecule active
Quick answer
PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO for post-COVID-19 Condition (PCC) is a Phase 2 program (small_molecule) at Meda AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Meda AB
- Indication
- post-COVID-19 Condition (PCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active